chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Epistaxis, Pain
Clinical narrative: Aches; Chills; Nose bleeds that last 20 minutes to 4 hours; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Aches), EPISTAXIS (Nose bleeds that last 20 minutes to 4 hours) and CHILLS (Chills) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 25-Apr-2021, the patient experienced EPISTAXIS (Nose bleeds that last 20 minutes to 4 hours). On an unknown date, the patient experienced PAIN (Aches) and CHILLS (Chills). At the time of the report, PAIN (Aches), EPISTAXIS (Nose bleeds that last 20 minutes to 4 hours) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Ear discomfort, Ear infection viral, Ear pain, Vertigo, Vestibular neuronitis
Clinical narrative: Ear Pain; Vestibular Neuritis; Vertigo; viral infection in the balance organ of the ear; fullness in the ear; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo), EAR INFECTION VIRAL (viral infection in the balance organ of the ear), EAR DISCOMFORT (fullness in the ear), VESTIBULAR NEURONITIS (Vestibular Neuritis) and EAR PAIN (Ear Pain) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included MULTIVITAMIN [VITAMINS NOS], COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]), IRON, FISH OIL, VITAMIN C [ASCORBIC ACID] and DICYCLOVERINE HYDROCHLORIDE, MEFENAMIC ACID (DIM [DICYCLOVERINE HYDROCHLORIDE;MEFENAMIC ACID]) for an unknown indication.    On 02-Apr-2021 at 12:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced EAR INFECTION VIRAL (viral infection in the balance organ of the ear) and EAR DISCOMFORT (fullness in the ear). On 23-Apr-2021 at 4:00 AM, the patient experienced VERTIGO (Vertigo). 23-Apr-2021 at 4:00 AM, the patient experienced VESTIBULAR NEURONITIS (Vestibular Neuritis). On 24-Apr-2021, the patient experienced EAR PAIN (Ear Pain). On 23-Apr-2021 at 8:00 AM, VERTIGO (Vertigo) had resolved. On 14-May-2021, VESTIBULAR NEURONITIS (Vestibular Neuritis) had resolved. At the time of the report, EAR INFECTION VIRAL (viral infection in the balance organ of the ear), EAR DISCOMFORT (fullness in the ear) and EAR PAIN (Ear Pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication included DIM. Patient was given a steroid injection and was prescribed with unspecified antibiotic.  Patient visited ENT and performed hearing check, which was good. 23Apr2021 Called Teladoc; Performed Epley Manver   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: updated patient demographics,Race and pregnancy information, Concomitant medications added,Vaccine facility information updated, Anatomical Location for vaccination and events Vestibular Neuritis and ear pain were added. On 05-Aug-2021: Follow up information received on 05-AUG-2021 included no new information.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Oxygen saturation abnormal, Vomiting
Clinical narrative: Fluctuating oxygen levels; Violent vomiting; This spontaneous case was reported by a consumer and describes the occurrence of OXYGEN SATURATION ABNORMAL (Fluctuating oxygen levels) and VOMITING (Violent vomiting) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included COPD.    On 23-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, the patient experienced OXYGEN SATURATION ABNORMAL (Fluctuating oxygen levels) and VOMITING (Violent vomiting). At the time of the report, OXYGEN SATURATION ABNORMAL (Fluctuating oxygen levels) and VOMITING (Violent vomiting) outcome was unknown. Not Provided          No concomitant medication provided. No treatment information provided.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Retching, Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: I got the dry heaves; I got a rash on my arm. it itched; I got a rash on my arm. It was about 6 inches long; I got a rash on my arm. It was red; This spontaneous case was reported by a consumer and describes the occurrence of RETCHING (I got the dry heaves), VACCINATION SITE PRURITUS (I got a rash on my arm. it itched), VACCINATION SITE RASH (I got a rash on my arm. It was about 6 inches long) and VACCINATION SITE ERYTHEMA (I got a rash on my arm. It was red) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (I got a rash on my arm. it itched), VACCINATION SITE RASH (I got a rash on my arm. It was about 6 inches long) and VACCINATION SITE ERYTHEMA (I got a rash on my arm. It was red). On 23-Apr-2021, the patient experienced RETCHING (I got the dry heaves). At the time of the report, RETCHING (I got the dry heaves), VACCINATION SITE PRURITUS (I got a rash on my arm. it itched), VACCINATION SITE RASH (I got a rash on my arm. It was about 6 inches long) and VACCINATION SITE ERYTHEMA (I got a rash on my arm. It was red) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided. Treatment medication include calamine lotion.   This case was linked to US-MODERNATX, INC.-MOD-2021-095547, US-MODERNATX, INC.-MOD-2021-095735 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: TCR added. Spoke with husband of the patient. Patient is fine and recovered from reactions she experienced. He declined further Follow-up.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-095547:Sister-in-law case US-MODERNATX, INC.-MOD-2021-095735:
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hypoaesthesia
Clinical narrative: felt a little tired; numbness of arm traveling up neck; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (felt a little tired) and HYPOAESTHESIA (numbness of arm traveling up neck) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, the patient experienced HYPOAESTHESIA (numbness of arm traveling up neck). On an unknown date, the patient experienced FATIGUE (felt a little tired). At the time of the report, FATIGUE (felt a little tired) and HYPOAESTHESIA (numbness of arm traveling up neck) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-094856 (Patient Link).
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: feeling nauseas; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (feeling nauseas) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced NAUSEA (feeling nauseas). On 08-Apr-2021, NAUSEA (feeling nauseas) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment information was  provided.    This case was linked to MOD-2021-094678 (Patient Link).
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Lip swelling, Pruritus, Rash macular
Clinical narrative: red all over the body, itchy; blotchy; lips feels like they are swelling up; red all over the body, itchy; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red all over the body, itchy), RASH MACULAR (blotchy), LIP SWELLING (lips feels like they are swelling up) and PRURITUS (red all over the body, itchy) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (red all over the body, itchy), RASH MACULAR (blotchy), LIP SWELLING (lips feels like they are swelling up) and PRURITUS (red all over the body, itchy). At the time of the report, ERYTHEMA (red all over the body, itchy), RASH MACULAR (blotchy), LIP SWELLING (lips feels like they are swelling up) and PRURITUS (red all over the body, itchy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment details were provided.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Feeling hot, Headache
Clinical narrative: sweating; warm to the touch; joint pain; now has a temperature of 101.4; muscle aches; Headache; fatigued; chills; Still is fatigued; has a headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating), FEELING HOT (warm to the touch), ARTHRALGIA (joint pain), PYREXIA (now has a temperature of 101.4) and MYALGIA (muscle aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, the patient experienced HYPERHIDROSIS (sweating), FEELING HOT (warm to the touch), ARTHRALGIA (joint pain), PYREXIA (now has a temperature of 101.4), MYALGIA (muscle aches), HEADACHE (Headache), FATIGUE (fatigued), CHILLS (chills) and HEADACHE (has a headache). 28-Apr-2021, the patient experienced FATIGUE (Still is fatigued). At the time of the report, HYPERHIDROSIS (sweating), FEELING HOT (warm to the touch), ARTHRALGIA (joint pain), PYREXIA (now has a temperature of 101.4), MYALGIA (muscle aches), HEADACHE (Headache), FATIGUE (fatigued), CHILLS (chills), FATIGUE (Still is fatigued) and HEADACHE (has a headache) outcome was unknown.            Treatment drugs include Aspirin and Tylenol.
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Myalgia, Pyrexia
Clinical narrative: sweating; warm to the touch; joint pain; now has a temperature of 101.4; muscle aches; Headache; fatigued; chills; Still is fatigued; has a headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating), FEELING HOT (warm to the touch), ARTHRALGIA (joint pain), PYREXIA (now has a temperature of 101.4) and MYALGIA (muscle aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, the patient experienced HYPERHIDROSIS (sweating), FEELING HOT (warm to the touch), ARTHRALGIA (joint pain), PYREXIA (now has a temperature of 101.4), MYALGIA (muscle aches), HEADACHE (Headache), FATIGUE (fatigued), CHILLS (chills) and HEADACHE (has a headache). 28-Apr-2021, the patient experienced FATIGUE (Still is fatigued). At the time of the report, HYPERHIDROSIS (sweating), FEELING HOT (warm to the touch), ARTHRALGIA (joint pain), PYREXIA (now has a temperature of 101.4), MYALGIA (muscle aches), HEADACHE (Headache), FATIGUE (fatigued), CHILLS (chills), FATIGUE (Still is fatigued) and HEADACHE (has a headache) outcome was unknown.            Treatment drugs include Aspirin and Tylenol.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Facial pain, Muscle spasms
Clinical narrative: face pain; muscle spasms in neck; This spontaneous case was reported by a consumer and describes the occurrence of FACIAL PAIN (face pain) and MUSCLE SPASMS (muscle spasms in neck) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043b21a) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, the patient experienced FACIAL PAIN (face pain) and MUSCLE SPASMS (muscle spasms in neck). At the time of the report, FACIAL PAIN (face pain) and MUSCLE SPASMS (muscle spasms in neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information was reported.  Treatment information was not reported.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain
Clinical narrative: left arm is painful where she got the vaccine; left arm is red where she got the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (left arm is red where she got the vaccine) and VACCINATION SITE PAIN (left arm is painful where she got the vaccine) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced VACCINATION SITE ERYTHEMA (left arm is red where she got the vaccine). On 20-Apr-2021, the patient experienced VACCINATION SITE PAIN (left arm is painful where she got the vaccine). At the time of the report, VACCINATION SITE ERYTHEMA (left arm is red where she got the vaccine) and VACCINATION SITE PAIN (left arm is painful where she got the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.  No treatment information was provided.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dysgraphia, Hypoaesthesia, Neuralgia, Pain
Clinical narrative: pain wakes her up at night; Trouble writing or scratching; pinkie is numb; whole arm nerve pain that constantly wakes her up at night; Shooting pain; joint pain; injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of NEURALGIA (whole arm nerve pain that constantly wakes her up at night), DYSGRAPHIA (Trouble writing or scratching), HYPOAESTHESIA (pinkie is numb), SLEEP DISORDER (pain wakes her up at night) and PAIN (Shooting pain) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced NEURALGIA (whole arm nerve pain that constantly wakes her up at night), HYPOAESTHESIA (pinkie is numb), PAIN (Shooting pain), ARTHRALGIA (joint pain) and VACCINATION SITE PAIN (injection site pain). On 24-Apr-2021, the patient experienced DYSGRAPHIA (Trouble writing or scratching) and SLEEP DISORDER (pain wakes her up at night). At the time of the report, NEURALGIA (whole arm nerve pain that constantly wakes her up at night), DYSGRAPHIA (Trouble writing or scratching), HYPOAESTHESIA (pinkie is numb), SLEEP DISORDER (pain wakes her up at night), PAIN (Shooting pain), ARTHRALGIA (joint pain) and VACCINATION SITE PAIN (injection site pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were taken. Treatment medication included Motrin 200 mg to relieve symptoms of pain.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Sleep disorder, Vaccination site pain
Clinical narrative: pain wakes her up at night; Trouble writing or scratching; pinkie is numb; whole arm nerve pain that constantly wakes her up at night; Shooting pain; joint pain; injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of NEURALGIA (whole arm nerve pain that constantly wakes her up at night), DYSGRAPHIA (Trouble writing or scratching), HYPOAESTHESIA (pinkie is numb), SLEEP DISORDER (pain wakes her up at night) and PAIN (Shooting pain) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced NEURALGIA (whole arm nerve pain that constantly wakes her up at night), HYPOAESTHESIA (pinkie is numb), PAIN (Shooting pain), ARTHRALGIA (joint pain) and VACCINATION SITE PAIN (injection site pain). On 24-Apr-2021, the patient experienced DYSGRAPHIA (Trouble writing or scratching) and SLEEP DISORDER (pain wakes her up at night). At the time of the report, NEURALGIA (whole arm nerve pain that constantly wakes her up at night), DYSGRAPHIA (Trouble writing or scratching), HYPOAESTHESIA (pinkie is numb), SLEEP DISORDER (pain wakes her up at night), PAIN (Shooting pain), ARTHRALGIA (joint pain) and VACCINATION SITE PAIN (injection site pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were taken. Treatment medication included Motrin 200 mg to relieve symptoms of pain.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Left side Swollen lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Left side Swollen lymph nodes) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced LYMPHADENOPATHY (Left side Swollen lymph nodes). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 15-Apr-2021, LYMPHADENOPATHY (Left side Swollen lymph nodes) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information was provided.  The patients treatment information included Tylenol.   This case was linked to MOD-2021-094928 (Patient Link).
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain
Clinical narrative: left arm is red where she got the vaccine; left arm is painful where she got the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (left arm is red where she got the vaccine) and VACCINATION SITE PAIN (left arm is painful where she got the vaccine) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (left arm is red where she got the vaccine) and VACCINATION SITE PAIN (left arm is painful where she got the vaccine). At the time of the report, VACCINATION SITE ERYTHEMA (left arm is red where she got the vaccine) and VACCINATION SITE PAIN (left arm is painful where she got the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lethargy
Clinical narrative: Lethargic; slight throbbing headache on the left side; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Lethargic) and HEADACHE (slight throbbing headache on the left side) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 067C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Apr-2021, the patient experienced LETHARGY (Lethargic) and HEADACHE (slight throbbing headache on the left side). At the time of the report, LETHARGY (Lethargic) and HEADACHE (slight throbbing headache on the left side) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included extra strength Tylenol.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Product dose omission issue
Clinical narrative: Headache; for second dose interval is more than 36 days; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and PRODUCT DOSE OMISSION ISSUE (for second dose interval is more than 36 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced HEADACHE (Headache) and PRODUCT DOSE OMISSION ISSUE (for second dose interval is more than 36 days). At the time of the report, HEADACHE (Headache) and PRODUCT DOSE OMISSION ISSUE (for second dose interval is more than 36 days) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications provided by reporter No Treatment medications provided by reporter   Reporter did not allow further contact
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test, Vaccination failure
Clinical narrative: Negative antibodies; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION FAILURE (Negative antibodies) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     The patient's past medical history included Back injury in 1989. Concurrent medical conditions included Disease Crohns since 2004, Asthma since 1973, Hypertension since 2004, Anxiety since 2004 and Drug allergy (Cephalosporin). Concomitant products included LORAZEPAM (ATIVAN) for Anxiety, ALBUTEROL [SALBUTAMOL] for Asthma, TIZANIDINE HYDROCHLORIDE (TIZADINE) for Back injury, INFLIXIMAB (REMICADE) for Crohns disease aggravated, LISINOPRIL for Hypertension, RANITIDINE and HYDROCODONE BITARTRATE, PARACETAMOL (NORCO) for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced VACCINATION FAILURE (Negative antibodies). At the time of the report, VACCINATION FAILURE (Negative antibodies) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Apr-2021, SARS-CoV-2 antibody test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.  Company comment: This report refers to a case of vaccination failure (negative antibodies)  for mRNA-1273, ( lot # 030A21A) with no associated AEs.   This case was linked to US-MODERNATX, INC.-MOD-2021-094954 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Follow up document was received on 29-Jul-2021.Added relevant medical history, concomitant medications, lad data, Event start date.; Sender's Comments: This report refers to a case of vaccination failure (negative antibodies)  for mRNA-1273, ( lot # 030A21A) with no associated AEs. US-MODERNATX, INC.-MOD-2021-094954:Husband case
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: red mass on her left shoulder deltoid region; Mass is itchy; Mass is painful; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE ERYTHEMA (red mass on her left shoulder deltoid region), VACCINATION SITE PRURITUS (Mass is itchy) and VACCINATION SITE PAIN (Mass is painful) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (red mass on her left shoulder deltoid region), VACCINATION SITE PRURITUS (Mass is itchy) and VACCINATION SITE PAIN (Mass is painful). At the time of the report, VACCINATION SITE ERYTHEMA (red mass on her left shoulder deltoid region), VACCINATION SITE PRURITUS (Mass is itchy) and VACCINATION SITE PAIN (Mass is painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   patient is on concomitant medication opioids.   Reporter did not allow further contact
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: joint pain; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 28-Apr-2021 and was forwarded to Moderna on 28-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (joint pain) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 001B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced ARTHRALGIA (joint pain). At the time of the report, ARTHRALGIA (joint pain) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Relevant concomitant medications was reported.  Treatment information included Tramadol.   This case was linked to MOD-2021-094760 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Missed 2nd dose of Moderna vaccine before 36 days; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose of Moderna vaccine before 36 days) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose of Moderna vaccine before 36 days). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose of Moderna vaccine before 36 days) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: Hair started to fall off, hasn't stop falling off; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ALOPECIA (Hair started to fall off, hasn't stop falling off) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003b21a) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced ALOPECIA (Hair started to fall off, hasn't stop falling off). At the time of the report, ALOPECIA (Hair started to fall off, hasn't stop falling off) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication list was not provided. Treatment information was not provided.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Product administered to patient of inappropriate age
Clinical narrative: sore arm; Received 1st dose Moderna COVID19 vaccine at 17 years old; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received 1st dose Moderna COVID19 vaccine at 17 years old) and PAIN IN EXTREMITY (sore arm) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received 1st dose Moderna COVID19 vaccine at 17 years old). On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received 1st dose Moderna COVID19 vaccine at 17 years old) and PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   concomitant medications were not provided. Treatment information were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: FU Received. New Event Added
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Vaccination site pain
Clinical narrative: dizziness; cried due to injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness) and VACCINATION SITE PAIN (cried due to injection site pain) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced VACCINATION SITE PAIN (cried due to injection site pain). On an unknown date, the patient experienced DIZZINESS (dizziness). At the time of the report, VACCINATION SITE PAIN (cried due to injection site pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Device connection issue
Clinical narrative: nothing in the syringe and had to administer it again; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DEVICE CONNECTION ISSUE (nothing in the syringe and had to administer it again) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DEVICE CONNECTION ISSUE (nothing in the syringe and had to administer it again). At the time of the report, DEVICE CONNECTION ISSUE (nothing in the syringe and had to administer it again) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitants were reported. No treatment was reported.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Vaccination site anaesthesia
Clinical narrative: experiencing numbness of the arm which travels up the neck; experiencing numbness of the arm which travels up the neck; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ANAESTHESIA (experiencing numbness of the arm which travels up the neck) and HYPOAESTHESIA (experiencing numbness of the arm which travels up the neck) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039B21A and 031B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Apr-2021, the patient experienced VACCINATION SITE ANAESTHESIA (experiencing numbness of the arm which travels up the neck) and HYPOAESTHESIA (experiencing numbness of the arm which travels up the neck). At the time of the report, VACCINATION SITE ANAESTHESIA (experiencing numbness of the arm which travels up the neck) and HYPOAESTHESIA (experiencing numbness of the arm which travels up the neck) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information provided. The action taken with  mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.   This case was linked to MOD-2021-094799 (Patient Link).
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Bone pain, Feeling abnormal, Pyrexia
Clinical narrative: every bone in my body hurts, down to my ankles; both her and her husband don't feel like themselves.; temperature of 99.6 for two days; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (every bone in my body hurts, down to my ankles), FEELING ABNORMAL (both her and her husband don't feel like themselves.) and PYREXIA (temperature of 99.6 for two days) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concomitant products included CARBIDOPA, LEVODOPA (CARBIDOPA/LEVODOPA), GABAPENTIN, CARVEDILOL, SITAGLIPTIN PHOSPHATE (JANUVIA [SITAGLIPTIN PHOSPHATE]), DULOXETINE, FENOFIBRATE, TOLTERODINE L-TARTRATE (TOLTERODIN), PRAVASTATIN and ACETYLSALICYLIC ACID (ASPIRIN) for an unknown indication.   On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced PYREXIA (temperature of 99.6 for two days). On an unknown date, the patient experienced BONE PAIN (every bone in my body hurts, down to my ankles) and FEELING ABNORMAL (both her and her husband don't feel like themselves.). On 01-Mar-2021, PYREXIA (temperature of 99.6 for two days) had resolved. At the time of the report, BONE PAIN (every bone in my body hurts, down to my ankles) and FEELING ABNORMAL (both her and her husband don't feel like themselves.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99.6 (Inconclusive) 99.6.         Action taken with mRNA-1273 in response to the events was not Applicable.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Hypertension, Pain in extremity
Clinical narrative: Blood pressure had gone up; Her injected arm hurts on and off; got real dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (got real dizzy), HYPERTENSION (Blood pressure had gone up) and PAIN IN EXTREMITY (Her injected arm hurts on and off) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030B21A and 0045A21A) for COVID-19 vaccination.     no medical history was reported.  Concomitant products included high blood pressure for Blood pressure, ATENOLOL for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Apr-2021, the patient experienced DIZZINESS (got real dizzy). On 28-Apr-2021, the patient experienced PAIN IN EXTREMITY (Her injected arm hurts on and off). On an unknown date, the patient experienced HYPERTENSION (Blood pressure had gone up). At the time of the report, DIZZINESS (got real dizzy), HYPERTENSION (Blood pressure had gone up) and PAIN IN EXTREMITY (Her injected arm hurts on and off) outcome was unknown. Not Provided          blood pressure started going up on 17Apr2021. Consent to follow up by email by safety team   This case was linked to MOD21-083320, US-MODERNATX, INC.-MOD-2021-094953 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Significant follow-up.Product tab: Added product batch information along with the administered date.Event tab: Added an event of arms hurting.; Sender's Comments:  MOD21-083320: US-MODERNATX, INC.-MOD-2021-094953:
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Oral herpes
Clinical narrative: Patient woke up with cold sores of mouth; This spontaneous case was reported by a consumer and describes the occurrence of ORAL HERPES (Patient woke up with cold sores of mouth) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MAGNESIUM and VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, the patient experienced ORAL HERPES (Patient woke up with cold sores of mouth). The patient was treated with VALACICLOVIR HYDROCHLORIDE (VALTREX) on 28-Apr-2021 at a dose of 2000 milligram. At the time of the report, ORAL HERPES (Patient woke up with cold sores of mouth) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       2nd dose is scheduled today 28Apr2021 which patient states she plans to receive. Asking if there is a drug interaction between Valtrex and the Moderna COVID19 vaccine? Reports no other side effects since receiving first dose of Moderna COVID19 vaccine on 30Mar2021.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: Headache / strong headache; Temperature; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache / strong headache) and PYREXIA (Temperature) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0011621A) for COVID-19 vaccination.     No medical history was provided by the reporter.  The patient's past medical history included COVID-19 (Previously infected with SARS-CoV2 on Jun2020. Lasted 3 weeks to a month) in June 2020 and Breathing difficult. Concomitant products included TOCOPHEROL (VITAMIN E NAT) and CYANOCOBALAMIN (VITAMIN B 12 [CYANOCOBALAMIN]) for an unknown indication.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced HEADACHE (Headache / strong headache) and PYREXIA (Temperature). The patient was treated with ACETAMINOPHEN on 28-Apr-2021 for Headache, at a dose of 500 mg/8 hours. At the time of the report, HEADACHE (Headache / strong headache) and PYREXIA (Temperature) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-095085 (E2B Linked Report).; Sender's Comments:  MOD-2021-095085:
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Covid-19 Tested Positive; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Covid-19 Tested Positive) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Covid-19 Tested Positive). At the time of the report, SARS-COV-2 TEST POSITIVE (Covid-19 Tested Positive) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported Treatment information was not provided
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Influenza like illness, Pain
Clinical narrative: Flu like symptoms; Feeling Achy; Feeling supper exhausted; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN (Feeling Achy) and FATIGUE (Feeling supper exhausted) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN (Feeling Achy) and FATIGUE (Feeling supper exhausted). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 10-Apr-2021, INFLUENZA LIKE ILLNESS (Flu like symptoms) and PAIN (Feeling Achy) had resolved. At the time of the report, FATIGUE (Feeling supper exhausted) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  The symptoms started 3 to 4 hours after receiving the vaccine and it got worse 6hours after receiving the vaccine. The symptoms lasted for about a week, but he still feels exhausted.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Malaise, Pain, Pyrexia
Clinical narrative: achy; Feeling unwell; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (achy), MALAISE (Feeling unwell) and PYREXIA (Fever) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (achy), MALAISE (Feeling unwell) and PYREXIA (Fever). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency. At the time of the report, PAIN (achy), MALAISE (Feeling unwell) and PYREXIA (Fever) outcome was unknown. Unknown    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99.7 (High) Body temperature-high.         No concomitant medications were provided.   Treatment with Aspirin was provided.  Action taken with mRNA-1273 in response to the event was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chest pain, Headache, Heart rate increased, Lymphadenopathy
Clinical narrative: Fast heartbeat; Chest pain; Sore neck; Sore arm; Bad headaches; fever; Swollen glands; Achy joints; achy muscles; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Fast heartbeat), CHEST PAIN (Chest pain), NECK PAIN (Sore neck), PAIN IN EXTREMITY (Sore arm) and HEADACHE (Bad headaches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (Fast heartbeat), CHEST PAIN (Chest pain), NECK PAIN (Sore neck), PAIN IN EXTREMITY (Sore arm), HEADACHE (Bad headaches), PYREXIA (fever), LYMPHADENOPATHY (Swollen glands), ARTHRALGIA (Achy joints) and MYALGIA (achy muscles). At the time of the report, HEART RATE INCREASED (Fast heartbeat), CHEST PAIN (Chest pain), NECK PAIN (Sore neck), PAIN IN EXTREMITY (Sore arm), HEADACHE (Bad headaches), PYREXIA (fever), LYMPHADENOPATHY (Swollen glands), ARTHRALGIA (Achy joints) and MYALGIA (achy muscles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information provided was Tylenol.